PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[midastouch017]

Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

https://finance.yahoo.com/news/protalix-biotherapeutics-present-canaccord-genuity-105000240.html

CARMIEL, Israel, Aug. 1, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein expression system, today announced that Dror Bashan, the Company's President and Chief Executive Officer, will present on Wednesday, August 9, 2023 at 3:30 p.m. Eastern Daylight Time (EDT) at the Canaccord Genuity 43rd Annual Growth Conference. The conference is being held on August 7-10, 2023 at the InterContinental Boston Hotel, Boston, MA.

Mr. Bashan will provide a live corporate overview at the conference, and the Company's management will participate in one-on-one meetings on August 7-9 with investors who are registered to attend the conference. A live and archived webcast of Mr. Bashan's presentation will be available as follows:

Live Presentation and Webcast Details:

Wednesday, August 9, 2023 at 3:30 p.m. Eastern Daylight Time (EDT)

Webcast Registration and Link: https://tinyurl.com/ms7sy4hu

The webcast will be available for replay for at least two weeks on the Events Calendar of the Investors section of the Company's website, https://protalixbiotherapeutics.gcs-web.com/events0.